Physician profile
Robert P Chen
NPI 1447276233
$422.78
in general payments reported to CMS, 2019-2025
11 companies · $148 in 2025
The $148 reported for 2025 was more than what a typical Geriatric Medicine (Family Medicine) provider received nationally (typical 2025 total: $119).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $16.18 · 2023: $69.94 · 2024: $189 · 2025: $148.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $407.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $406.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $100.31 | 2024-2025 | Wegovy, Rybelsus, Ozempic |
| Exact Sciences Corporation | $87.02 | 2023-2025 | Cologuard Collection Kit |
| Astrazeneca Pharmaceuticals Lp | $64.83 | 2023-2024 | Breztri |
| Abbvie INC. | $33.36 | 2021-2024 | |
| Rayner Intraocular Lenses Limited | $31.62 | 2024 | Omidria |
| Bayer Healthcare Pharmaceuticals INC. | $23.90 | 2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $18.70 | 2025 | Jardiance |
| Biogen, INC. | $18.31 | 2024 | Skyclarys |
| Lilly USA, LLC | $15.60 | 2025 | Mounjaro, Zepbound |
| Seqirus USA INC | $14.68 | 2024 | Flucelvax |
| Vital Connect, INC | $14.45 | 2025 | Vitalpatch Rtm |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Chen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.